Yhn HealthHealth first seen 1 d ago, last 54 min ago, peak #1

Moderna and Merck mRNA cancer vaccine cuts deaths 42%

Original: Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%

Moderna and Merck report that their personalized mRNA cancer vaccine reduced death and recurrence by 42% in melanoma patients. The therapy, built on the same mRNA platform used for COVID-19 vaccines, is tailored to individual tumors and given alongside immunotherapy. The results are being read as a major step toward personalized cancer treatment, with discussion focused on when the vaccine could reach approval.

Why now: New clinical data shows a striking survival benefit for a personalized mRNA cancer therapy, a milestone for the technology.

ModernaMerckmelanomamRNA cancer vaccine

Open on hn →

Rank over time, top of the chart is #1. 62 snapshots from 1 d ago to 54 min ago.

Evidence

• Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42% · _Microft · 190
• Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42% · nathcd · 6

API: https://socialmediatrends-api.osmike.com/v1/trends/3528419